In this issue of Cardiology Clinics, guest editors Drs. Eric H. Yang and Ashley F. Stein-Merlob bring their considerable expertise to the topic of Cardio-oncology. Top experts discuss key topics such as anthracycline-induced cardiotoxicity; cardiac complications of immunotherapy:: immune checkpoint inhibitors and CAR T cell therapy; advances in diagnosis and treatment of amyloid cardiomyopathy; guidelines in cardio-oncology; and more.
Cardiovascular Risk Assessment and Prevention in Cardio-Oncology: Beyond Traditional Risk Factors Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Health Unique Challenges of Adult Congenital Heart Disease in Cardio-Oncology Classes of Antineoplastic Agents Associated with Increased Risk of Cancer Therapy-associated Hypertension and Management Strategies Arrhythmia Challenges in Cardio-Oncology: High-Risk Therapies, Management, and Anticoagulation Ischemic Heart Disease in the Cancer Population: Trends, Outcomes, Epidemiology, and Challenges in Diagnosis and Treatment Cardiovascular Health in Breast Cancer: Survivorship Care Cardiovascular Risk in Prostate Cancer Evolving Strategies in Cardiac Amyloidosis: From Mechanistic Discoveries to Diagnostic and Therapeutic Advances Cardiotoxicity of Anthracyclines Cardiac Complications of Radiation Therapy Cardiac Complications of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy Cardio-oncology Drug Interactions: A Primer for Clinicians on Select Cardiotoxic Oncologic Therapies Cardio-Oncology Program Building: A Practical Guide
Komentarze (0)
Chwilowo nie możesz polubić tej opinii
Zgłoś komentarz
Czy jesteś pewien, że chcesz zgłosić ten komentarz?
Zgłoszenie wysłane
Twój komentarz został wysłany i będzie widoczny po zatwierdzeniu przez moderatora.